FIELD: chemistry.
SUBSTANCE: invention relates to a crystal form D of a compound of the formula I, which has a range of X-ray powder diffraction, obtained using Cu-Kα radiation and represented by a diffraction angle 2θ, which has characteristic peaks at diffraction angles 2θ: 8.41, 8.85, 11.38, 12.18, 13.45, 15.15, 16.73, 17.59, 17.68, 20.45, 21.51, 22.72, 24.53, 24.91, and 27.11, where a range of error of the angle 2θ of each characteristic peak is ±0.2. The crystal form D is obtained by dissolution of a compound of the formula I in a solvent for crystallization, filtration, and drying of the resulting crystal to obtain a desired crystal form D, where the solvent is selected from a group including methanol, isopropanol, simple ether solvent, mixed solvent of methanol and water, and mixed solvent of ethanol and water, wherein the simple ether solvent is 1,4-dioxane. A crystallization method is crystallization with evaporation of the solvent. The invention also relates to options of a method for the production of a crystal form D of a compound of the formula I. The crystal form D of the compound of the formula I, according to the invention, is intended for preparation of a drug for inhibition of EZH2.
EFFECT: crystal form D of a compound of the formula I, having a stability property.
5 cl, 17 dwg, 6 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOFURAN DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2016 |
|
RU2727198C2 |
APPLICATION OF AN EZH2 INHIBITOR IN COMBINATION WITH A BTK INHIBITOR IN PRODUCTION OF A MEDICINAL PRODUCT FOR TREATING A TUMOUR | 2018 |
|
RU2762893C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP | 2015 |
|
RU2707953C2 |
SALT FORM OF HUMAN HISTONE METHYLTRANSERASE EZH2 INHIBITOR | 2013 |
|
RU2658911C2 |
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2632193C2 |
METHOD FOR PRODUCTION OF BENZOFURAN DERIVATIVE | 2018 |
|
RU2777624C2 |
NOVEL CRYSTALLINE FORMS OF DIPEPTIDYLPEPTIDASE-IV INHIBITORS | 2012 |
|
RU2598072C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
TOSYLATE SALT OF 5-PYRAZOLYL-2-PYRIDONE DERIVATIVE EFFECTIVE IN COPD TREATMENT | 2010 |
|
RU2526038C2 |
Authors
Dates
2023-03-03—Published
2018-05-17—Filed